Core Viewpoint - The company, Wihua New Materials, is acquiring a 70% stake in Jiangsu Heyutai Chemical from Zhejiang Xinhhe Biological for a transaction price of 154 million yuan, aiming to turn the target company profitable by 2026 [1] Group 1: Acquisition Details - The acquisition will be funded through the company's own funds and bank loans [1] - After the acquisition, Heyutai will become a controlled subsidiary of Wihua New Materials [1] Group 2: Financial Performance of Target Company - Heyutai is currently in a loss-making phase due to low market prices for agricultural chemical products and insufficient capacity utilization [1] - However, there are signs of improvement, with losses in the first half of 2025 narrowing compared to the same period last year, and further operational improvements expected in the third quarter [1] Group 3: Future Strategy - Post-acquisition, the company plans to expand sales channels, enhance capacity utilization, optimize product processes, and strengthen internal management to achieve profitability for Heyutai by 2026 [1] - The target company relies on three main raw materials that are also key products of Wihua and its subsidiaries, allowing for stable supply and reduced procurement uncertainties [1]
巍华新材(603310.SH)子公司拟1.54亿元收购禾裕泰70%股权